Neuronetics Share Price

Neuronetics Share Price

NASDAQ: STIM | Micro Cap | Healthcare
$1.26
+0.00 (0.00%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Neuronetics Stock Performance

Open
$1.26
Prev. Close
$1.26
Circuit Range
N/A
Day Range
$1.19 - $1.31
Year Range
$0.81 - $3.44
Volume
89,038
Average Traded
$1.27

Neuronetics Share Price Today

As of 19 November 2026, Neuronetics, Inc.'s share price is $1.26. The stock opened at $1.26, compared to its previous close of $1.26. During today's trading session, Neuronetics, Inc.'s share price traded between $1.19 and $1.31, with an average price of $1.25. Over the past 52 weeks, the stock has recorded a high of $3.44 and a low of $0.81. In terms of performance, Neuronetics, Inc.'s share price has declined by 18.12% over the last six months and is down 14.53% on a year-on-year basis.

Neuronetics Share Price Chart

Line chart of the Neuronetics price trend over the selected period. The price rose overall, ranging from 1.19 to 1.31, ending at 1.26.
$1.19$1.31
L
Show Current Price
H

Neuronetics Stock Fundamentals & Key Indicators

Market Cap
$83.43M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.24
Revenue (TTM)
$149.16B
Return On Equity (TTM)
-123.36%
Profit Margin
-26.15%
Debt to Equity
3.30
Quarterly Earnings Growth YoY
76.40%

Neuronetics Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$41.78$34.45$41.57$41.96
Net Profit-$7.16-$10.79-$3.44-$1.69
Net Profit Margin-17.14%-31.32%-8.28%-4.03%
Income ChangeN/A-50.70%68.12%50.87%

Neuronetics Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$65.21$71.35$74.89$149.16
Net Profit-$37.16-$30.19-$43.71-$39.00
Net Profit Margin-56.99%-42.31%-58.37%-26.15%
Income ChangeN/A18.76%-44.78%10.78%

Neuronetics Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets80.082.7822.0418.12
Current Assets61.5558.1293.7998.77
Total Assets141.55140.9115.83116.88
Non Current Liabilities84.7977.8461.8326.63
Current Liabilities30.5231.2719.8133.2
Total Liabilities115.31109.181.6459.82
Shareholders' Equity26.2431.834.1957.06

Neuronetics Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-20.37-31.0-32.04-30.74
Investing-0.8-2.41-1.326.73
Financing35.85-6.8122.70.21

About Neuronetics

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Neuronetics Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.36
$1.26
-43.90%
Oct 2026
$2.35
$2.25
-4.25%
Sep 2026
$2.81
$2.35
-20.57%
Aug 2026
$2.05
$2.96
+50.51%
Jul 2026
$1.30
$1.97
+51.54%
Jun 2026
$1.54
$1.30
-15.86%
May 2026
$1.97
$1.54
-19.95%
Apr 2026
$1.53
$1.93
+33.10%
Mar 2026
$1.25
$1.45
+8.61%
Feb 2026
$1.99
$1.33
-36.12%
Jan 2026
$1.39
$2.09
+51.45%
Dec 2025
$1.48
$1.38
-6.76%

Neuronetics Share Price FAQs